Objective: The clinical characteristics and outcomes of endometrial ca
ncer patients 45 years of age and younger were compared with those of
patients older than 45 years of age. Methods: We performed a cross-sec
tional study of 301 consecutive endometrial cancer patients referred t
o our center from 1989 to 1994. Of the 289 patients eligible for study
, 40 were 45 years of age or younger (group A) and 249 were older than
45 years of age (group B). Results: The majority of patients in both
groups presented with stage I disease. Of the women with stage I disea
se, patients in group A were more likely than those in group B to have
low-grade disease localized to the endometrium (P < .001; relative pr
evalence 3.39; confidence interval [CI] 1.88, 6.12). However, the dist
ribution of stages I to IV overall was the same for the two groups (P
= .269). Although univariate analysis revealed that 11% of the patient
s in group A and 2% in group B had synchronous ovarian malignancies (P
= .007; relative prevalence 5.42; CI 1.39, 21.14), multivariate logis
tic regression found that nulliparity, not age, was an independent ris
k factor for synchronous ovarian malignancy (P = .017; relative preval
ence 6.15; CI 1.52, 25.61). There were no statistically significant di
fferences by age in the prevalence of high-risk endometrial histology
(serous and clear cell carcinoma) or in survival. Conclusion: The over
all distribution of tumor stage and survival were the same for the you
nger and older women; this finding contradicts previous reports that s
uggest that young women with endometrial cancer are at lower risk. Add
itionally, nulliparity, which occurs with a higher prevalence in young
er women who develop endometrial cancer, is associated statistically w
ith the development of synchronous ovarian malignancies. (C) 1998 by T
he American College of Obstetricians and Gynecologists.